Targeted literature review of the burden of extraintestinal pathogenic Escherichia Coli among elderly patients in Asia Pacific regions

References

• Russo TA, Johnson JR. Medical and economic impact of extraintestinal infections due to Escherichia coli: focus on an increasingly important endemic problem. Microbes Infect. 2003;5(5):449–456.
   PubMed Web of Science ®Google Scholar
• Manges AR, Geum HM, Guo A, et al. Global Extraintestinal pathogenic Escherichia coli (ExPEC) lineages. Clin Microbiol Rev. 2019;32(3):e00135-18.
   PubMed Web of Science ®Google Scholar
• Poolman JT, Wacker M. Extraintestinal Pathogenic Escherichia coli, a common human pathogen: challenges for vaccine development and progress in the field. J Infect Dis. 2016;213(1):6–13.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Ikuta KS, Sharara F, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet. 2022;399(10325):629–655.
   PubMed Web of Science ®Google Scholar
• Leibovici L, Shraga I, Drucker M, et al. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Int Med. 1998;244(5):379–386.
   PubMed Web of Science ®Google Scholar
• Williamson D, Barrett LK, Rogers B, et al. Infectious complications following transrectal ultrasound-guided prostate biopsy: new challenges in the era of multidrug-resistant Escherichia coli. Clin Infect Dis. 2013;57(2):267–274.
   PubMed Web of Science ®Google Scholar
• Quan J, Zhao D, Liu L, et al. High prevalence of ESBL-producing Escherichia coli and Klebsiella pneumoniae in community-onset bloodstream infections in China. J Antimicrob Chemother. 2017;72(1):273–280.
   PubMed Web of Science ®Google Scholar
• Liu B. 2016-2017年成人血流感染临床特点和病原学分析2016-2017 Clinical characteristics and etiological analysis of adult bloodstream infections-Chongqing municipal health information center. Digital J System. 检验医学与临床. 2020;17(4):269. http://paper.cqshic.com/paper.aspx?id=194063
   Google Scholar
• Bai Y, Zheng Z, Du M, et al. Bloodstream Infection and its clinical characteristics and relevant factors associated with interventional therapy in a large tertiary hospital: a six years surveillance study. BioMed Res Int. 2019;2019:1–7.
   Web of Science ®Google Scholar
• Feng Q, Yuejuan S, Xiaoqin H. Epidemiology of pathogenic microorganisms, basic diseases and clinical biomarker analysis in patients with bloodstream infections from a 3A general hospital in Lanzhou of China. Afr J Microbiol Res. 14(7):332–339.
   Google Scholar
• Tian L, Zhang Z, Sun Z. Antimicrobial resistance trends in bloodstream infections at a large teaching hospital in China: a 20-year surveillance study (1998-2017). Antimicrob Resist Infect Control. 2019;8(1):86.
   PubMedGoogle Scholar
• Jiang Y, Li J, Zhang Y, et al. Clinical Situations of bacteriology and prognosis in patients with urosepsis. BioMed Res Int. 2019;2019:1–9.
   Web of Science ®Google Scholar
• Zhang Q, Zhang W, Li Z, et al. Bacteraemia due to AmpC β-lactamase-producing Escherichia coli in hospitalized cancer patients: risk factors, antibiotic therapy, and outcomes. Diagn Microbiol Infect Dis. 2017;88(3):247–251.
   PubMed Web of Science ®Google Scholar
• Xiao T, Wu Z, Shi Q, et al. A retrospective analysis of risk factors and outcomes in patients with extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections. J Glob Antimicrob Resist. 2019;17:147–156.
   PubMed Web of Science ®Google Scholar
• Kosai K, Yamagishi Y, Hashinaga K, et al. Multicenter surveillance of the epidemiology of gram-negative bacteremia in Japan. J Infect Chemother. 2020;26(3):193–198.
   PubMed Web of Science ®Google Scholar
• Mitsuboshi S, Tsuruma N, Watanabe K, et al. Advanced age is not a risk factor for mortality in patients with bacteremia caused by extended-spectrum β-lactamase-producing organisms: a multicenter cohort study. Jpn J Infect Dis. 2020;73(4):288–292.
   PubMed Web of Science ®Google Scholar
• Miyazato K, Natomi H, Shiroma Y, et al. Bacteremia in cholangiolithic cholangitis. Gastroenterol Endoscopy. 2018;60:2377–2386.
   Google Scholar
• Nagao M. A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals. Clin Microbiol Infect off Publ Eur Soc Clin Microbiol Infect Dis. 2013;19(9):852–858.
   PubMed Web of Science ®Google Scholar
• Takeshita N, Kawamura I, Kurai H, et al. Unique characteristics of community-onset healthcare- associated bloodstream infections: a multi-Centre prospective surveillance study of bloodstream infections in Japan. J Hosp Infect. 2017;96(1):29–34.
   PubMed Web of Science ®Google Scholar
• Hattori H, Maeda M, Nagatomo Y, et al. Epidemiology and risk factors for mortality in bloodstream infections: a single-center retrospective study in Japan. Am J Infect Control. 2018;46(12):e75–9–e79.
   Web of Science ®Google Scholar
• Komatsu Y, Kasahara K, Inoue T, et al. Molecular epidemiology and clinical features of extended-spectrum beta-lactamase- or carbapenemase-producing Escherichia coli bacteremia in Japan. PLoS ONE. 2018;13(8):e0202276.
   PubMed Web of Science ®Google Scholar
• Tsuzuki S, Matsunaga N, Yahara K, et al. National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan. J Infect Chemother. 2020;26(4):367–371.
   PubMed Web of Science ®Google Scholar
• Haruki Y, Hagiya H, Haruki M, et al. Clinical characteristics and outcome of critically ill patients with bacteremia caused by extended-spectrum β-lactamase-producing and non-producing Escherichia coli. J Infect Chemother. 2018;24(11):944–947.
   PubMed Web of Science ®Google Scholar
• Namikawa H, Yamada K, Fujimoto H, et al. Clinical characteristics of bacteremia caused by extended-spectrum beta-lactamase-producing Escherichia coli at a tertiary hospital. Intern Med. 2017;56(14):1807–1815.
   PubMed Web of Science ®Google Scholar
• Park DW, Chun BC, Kim JM, et al. Epidemiological and clinical characteristics of Community-Acquired severe sepsis and septic shock: a prospective observational study in 12 university hospitals in korea. J Korean Med Sci. 2012;27(11):1308–1314.
   PubMed Web of Science ®Google Scholar
• Son JS, Song JH, Ko KS, et al. Bloodstream infections and clinical significance of healthcare-associated bacteremia: a multicenter surveillance study in korean hospitals. J Korean Med Sci. 2010;25(7):992–998.
   PubMed Web of Science ®Google Scholar
• Liu C, Yoon EJ, Kim D, et al. Antimicrobial resistance in South Korea: a report from the korean global antimicrobial resistance surveillance system (Kor-GLASS) for 2017. J Infect Chemother. 2019;25(11):845–859. 1
   PubMed Web of Science ®Google Scholar
• Lee H, Yoon EJ, Kim D, et al. Antimicrobial resistance of major clinical pathogens in South Korea, may 2016 to april 2017: first one-year report from Kor-GLASS. Eurosurveillance. 2018;23(42):1800047.
   Web of Science ®Google Scholar
• Cho SY, Kang CI, Cha MK, Korean Network for Study on Infectious Diseases, et al. Clinical features and treatment outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing escherichia coli sequence type 131. Microb Drug Resist. 2015;21(4):463–469.
   PubMed Web of Science ®Google Scholar
• Yoon EJ, Choi MH, Park YS, et al. Impact of host-pathogen-treatment tripartite components on early mortality of patients with Escherichia coli bloodstream infection: prospective observational study. EBioMedicine. 2018;35:76–86.
   PubMed Web of Science ®Google Scholar
• Ku NS, Kim YC, Kim MH, et al. Risk factors for 28-day mortality in elderly patients with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia. Arch Gerontol Geriatr. 2014;58(1):105–109.
   PubMed Web of Science ®Google Scholar
• Ha YE, Kang CI, Cha MK, et al. Epidemiology and clinical outcomes of bloodstream infections caused by extended-spectrum β-lactamase-producing Escherichia coli in patients with cancer. Int J Antimicrob Agents. 2013;42(5):403–409.
   PubMed Web of Science ®Google Scholar
• Kang SJ, Jung SI, Wi YM, et al. Clinical characteristics and outcomes of community-onset acute pyelonephritis caused by Escherichia coli in elderly patients. Eur Geriatr Med. 2014;5(2):78–81.
   Web of Science ®Google Scholar
• Lee JH, Lee YM, Cho JH. Risk factors of septic shock in bacteremic acute pyelonephritis patients admitted to an ER. J Infect Chemother. 2012;18(1):130–133.
   PubMed Web of Science ®Google Scholar
• Hsieh WS, Tsai YT, Chi WM, et al. Epidemiology and prevalence of bloodstream infections in a regional hospital in Northern Taiwan during 2008-2013. J Exp Clin Med Taiwan. 2014;6(6):187–189.
   Google Scholar
• Lee CC, Lee CH, Hong MY, et al. Propensity-matched analysis of the impact of extended-spectrum β-lactamase production on adults with community-onset Escherichia coli, Klebsiella species, and Proteus mirabilis bacteremia. J Microbiol Immunol Infect. 2018;51(4):519–526.
   PubMedGoogle Scholar
• Lee JC, Lee NY, Lee HC, et al. Clinical characteristics of urosepsis caused by extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumonia and their emergence in the community. J Microbiol Immunol Infect. 2012;45(2):127–133.
   PubMedGoogle Scholar
• Australian Commission on Safety and Quality in Health Care. Australian Group on Antimicrobial Resistance. Sepsis outcome programs 2015 report. 2016.
   Google Scholar
• Kim J, Kim K, Lee H, et al. Epidemiology of sepsis in korea: a population-based study of incidence, mortality, cost and risk factors for death in sepsis. Clin Exp Emerg Med. 2019;6(1):49–63.
   PubMed Web of Science ®Google Scholar
• Wozniak TM, Bailey EJ, Graves N. Health and economic burden of antimicrobial-resistant infections in Australian hospitals: a population-based model. Infect Control Hosp Epidemiol. 2019;40(3):320–327.
   PubMed Web of Science ®Google Scholar
• Jiang W, Wu M, Zhou J, et al. Etiologic spectrum and occurrence of coinfections in children hospitalized with community-acquired pneumonia. BMC Infect Dis. 2017;17(1):787.
   PubMedGoogle Scholar
• Chen LF, Chiu CT, Lo JY, et al. Clinical characteristics and antimicrobial susceptibility pattern of hospitalised patients with community-acquired urinary tract infections at a regional hospital in Taiwan. Healthc Infect. 2014;19(1):20–25.
   Google Scholar
• Kim YA, Park YS, Youk T, et al. Trends in South Korean antimicrobial use and association with changes in Escherichia coli resistance rates: 12-year ecological study using a nationwide surveillance and antimicrobial prescription database. Karunasagar I, editor. PLoS ONE. 2018;13(12):e0209580.
   PubMed Web of Science ®Google Scholar
• Health protection: Infectious diseases - detailed information - GOV.UK. 2022. https://www.gov.uk/topic/health-protection/infectious-diseases
   Google Scholar
• Bonten M, Johnson JR, van den Biggelaar AHJ, et al. Epidemiology of Escherichia coli bacteremia: a systematic literature review. Clin Infect Dis. 2021;72(7):1211–1219.
   PubMed Web of Science ®Google Scholar
• Cosgrove SE, Kaye KS, Eliopoulous GM, et al. Health and economic outcomes of the emergence of Third-Generation cephalosporin resistance in Enterobacter species. Arch Intern Med. 2002;162(2):185–190.
   PubMedGoogle Scholar
• Tsuzuki S, Matsunaga N, Yahara K, et al. Disease burden of bloodstream infections caused by antimicrobial-resistant bacteria: a population-level study, Japan, 2015–2018. Int J Infect Dis. 2021;108:119–124.
   PubMed Web of Science ®Google Scholar
• Friedman ND, Temkin E, Carmeli Y. The negative impact of antibiotic resistance. Clin Microbiol Infect. 2016;22(5):416–422.
   PubMed Web of Science ®Google Scholar
• Matsumoto T, Darlington O, Miller R, et al. Estimating the economic and clinical value of reducing antimicrobial resistance to three gram-negative pathogens in Japan. J Health Econ Outcomes Res. 2021;8(2):64–75.
   PubMedGoogle Scholar
• World Health Organization. Regional Office for Europe. The fight against antimicrobial resistance is closely linked to the Sustainable Development Goals [Internet]. World Health Organization. Regional Office for Europe; 2020. Report No.: WHO/EURO:2020-1634-41385-56394. https://apps.who.int/iris/handle/10665/337519
   Google Scholar
• Akiyama H. Aging well: an update. Nutr Rev. 2020;78(12 Suppl 2):3–9.
   PubMedGoogle Scholar
• Fratamico PM, DebRoy C, Liu Y, et al. Advances in molecular serotyping and subtyping of Escherichia coli†. Front Microbiol. 2016;7:644.
   PubMed Web of Science ®Google Scholar